Natalie E. Stevens

641 citations

18 papers · 440 · h-index 10

Impact in

Microbiology top 5%
- Antimicrobial Peptides and Activities
Clinical Biochemistry top 10%
- Advanced Glycation End Products research

Papers in

Immunology 7
- Immune Response and Inflammation 4
- Immune responses and vaccinations 2
Epidemiology 5
- Influenza Virus Research Studies 2
- Sepsis Diagnosis and Treatment 2

Co-authors: John D. Hayball (8 shared papers)Kerrilyn R. Diener (6 shared papers)Marianne J. Chapman (3 shared papers)Cara K. Fraser (4 shared papers)Laurence Meagher (2 shared papers)Almar Postma (2 shared papers)Krasimir Vasilev (2 shared papers)Hans J. Griesser (2 shared papers)
Journals: Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Vaccine (1 paper)Cell Reports Medicine (1 paper)International Journal of Molecular Sciences (1 paper)
Partner nations: Australia Slovakia United Kingdom

In The Last Decade

Natalie E. Stevens

18 papers receiving 438 citations

Peers

Countries citing papers authored by Natalie E. Stevens

Since Specialization

Citations

This map shows the geographic impact of Natalie E. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie E. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie E. Stevens more than expected).

Fields of papers citing papers by Natalie E. Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie E. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie E. Stevens. The network helps show where Natalie E. Stevens may publish in the future.

Co-authors

The 25 scholars most cited alongside Natalie E. Stevens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Natalie E. Stevens Line = papers co-authored together Natalie E. Stevens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Antimicrobial Polymethacrylates Synthesized as Mimics of Tryptophan-Rich Cationic Peptides ACS Macro Letters ·Katherine E. S. Locock, Thomas D. Michl, Natalie E. Stevens, John D. Hayball, Krasimir Vasilev, Almar Postma, Hans J. Griesser, Laurence Meagher, Matthias Haeussler	2014	94
2	Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes Scientific Reports ·Natalie E. Stevens, Marianne J. Chapman, Cara K. Fraser, Tim Kuchel, John D. Hayball, Kerrilyn R. Diener	2017	90
3	RAFT-derived antimicrobial polymethacrylates: elucidating the impact of end-groups on activity and cytotoxicity Polymer Chemistry ·Thomas D. Michl, Katherine E. S. Locock, Natalie E. Stevens, John D. Hayball, Krasimir Vasilev, Almar Postma, Yue Qu, Ana Traven, Matthias Haeussler, Laurence Meagher, Hans J. Griesser	2014	66
4	Depletion of high‐affinity corticosteroid‐binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications Clinical Endocrinology ·Marni Nenke, Wayne Rankin, Marianne J. Chapman, Natalie E. Stevens, Kerrilyn R. Diener, John D. Hayball, John G. Lewis, David J. Torpy	2014	45
5	The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota Cell Reports Medicine ·Stephen J. Blake, Jane James, Feargal J. Ryan, José A. Caparrós‐Martín, Georgina L. Eden, Yee C. Tee, John Salamon, Saoirse C. Benson, Damon J. Tumes, Anastasia Sribnaia, Natalie E. Stevens, John Finnie, Hiroki Kobayashi, Deborah L. White, Steve Wesselingh, Fergal O’Gara, Miriam A. Lynn, David J. Lynn	2021	26
6	Xenografts — future prospects for clinical transplantation Immunology Letters ·Thomas Cairns, David Taube, Natalie E. Stevens, R M Binns, Ken I. Welsh	1991	25
7	Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin Frontiers in Immunology ·Natalie E. Stevens, Allison J. Cowin, Zlatko Kopecki	2019	21
8	Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease Frontiers in Immunology ·Zlatko Kopecki, Natalie E. Stevens, Heng Thay Chong, Gink N. Yang, Allison J. Cowin	2018	15
9	CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1 Journal of Immunological Methods ·Nerissa Lakhan, Natalie E. Stevens, Kerrilyn R. Diener, John D. Hayball	2016	12
10	Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection Scientific Reports ·Natalie E. Stevens, Antoinette Hatjopolous, Cara K. Fraser, Mohammed Alsharifi, Kerrilyn R. Diener, John D. Hayball	2016	9
11	Recombinant Leucine-Rich Repeat Flightless-Interacting Protein-1 Improves Healing of Acute Wounds through Its Effects on Proliferation Inflammation and Collagen Deposition International Journal of Molecular Sciences ·Zlatko Kopecki, Natalie E. Stevens, Gink N. Yang, Elizabeth Melville, Allison J. Cowin	2018	9
12	Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice Vaccine ·Natalie E. Stevens, Marjolein van Wolfswinkel, Winnie Bao, Feargal J. Ryan, Byron Brook, Nelly Amenyogbe, Helen Marshall, Miriam A. Lynn, Tobias R. Kollmann, Damon J. Tumes, David J. Lynn	2021	8
13	An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT™ Is Functionally Superior to Freund's Adjuvant PLoS ONE ·Natalie E. Stevens, Cara K. Fraser, Mohammed Alsharifi, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball	2013	8
14	Diet at birth is critical for healthy growth, independent of effects on the gut microbiota Microbiome ·Lieke J. W. van den Elsen, Akila Rekima, Miriam A. Lynn, C. Isnard, Savannah Machado, Nivedithaa Divakara, Diana Patalwala, A.M. Middleton, Natalie E. Stevens, Florence Servant, Rémy Burcelin, David J. Lynn, Valérie Verhasselt	2024	5
15	Overcoming the challenges of topical antibody administration for improving healing outcomes: a review of recent laboratory and clinical approaches. Adelaide Research & Scholarship (AR&S) (University of Adelaide) ·Natalie E. Stevens, Allison J. Cowin	2017	3
16	Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial EBioMedicine ·Nicole L. Messina, Susie Germano, Rebecca McElroy, Rhian Bonnici, Branka Grubor‐Bauk, David J. Lynn, Ellie McDonald, Suellen Nicholson, Kirsten P. Perrett, Laure F. Pittet, Rajeev Rudraraju, Natalie E. Stevens, Kanta Subbarao, Nigel Curtis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	2
17	Acute urinary tract infection elicits bladder afferent hypersensitivity Brain Behavior & Immunity - Health ·Harman Sharma, Sarah K Manning, Natalie E. Stevens, Georgia Bourlotos, Feargal J. Ryan, Cindy Tay, Sonja Klebe, Geraint B. Rogers, Miriam A. Lynn, Steven Taylor, Luke Grundy	2025	1
18	High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care support Experimental and Therapeutic Medicine ·Natalie E. Stevens, C. Nash, Cara K. Fraser, Tim Kuchel, Matthew J. Maiden, Marianne J. Chapman, Kerrilyn R. Diener, John D. Hayball	2019	1

About Natalie E. Stevens

Natalie E. Stevens is a scholar working on Immunology, Epidemiology, Clinical Biochemistry, Organic Chemistry and Surgery, having authored 18 papers that have together received 440 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Advanced Glycation End Products research (3 papers), Antimicrobial Peptides and Activities (2 papers), Influenza Virus Research Studies (2 papers), Antimicrobial agents and applications (2 papers), Immune responses and vaccinations (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Autoimmune Bullous Skin Diseases (1 paper). The work is most often cited by research in Microbiology (80 citations), Clinical Biochemistry (44 citations), Organic Chemistry (134 citations), Immunology (96 citations) and Behavioral Neuroscience (15 citations). Natalie E. Stevens has collaborated with scholars based in Australia, Slovakia and United Kingdom. Frequent co-authors include John D. Hayball, Kerrilyn R. Diener, Marianne J. Chapman, Cara K. Fraser, Laurence Meagher, Almar Postma, Krasimir Vasilev, Hans J. Griesser, Katherine E. S. Locock and Thomas D. Michl. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, Vaccine, Cell Reports Medicine and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Natalie E. Stevens

Impact in

Papers in i

In The Last Decade

Natalie E. Stevens

Peers

Countries citing papers authored by Natalie E. Stevens

Fields of papers citing papers by Natalie E. Stevens

All Works

About Natalie E. Stevens

Explore authors with similar magnitude of impact

Papers in